Abstract
Increasingly, it has been recognized that studying cancer samples from individual patients is important for the development of effective therapeutic strategies and in endeavors to overcome therapy resistance. Primary cultures of cancer cells acutely dissected from individual patients can provide a platform that enables the study and characterization of individual tumors. To that end, we have developed a method for preparing cancer cells in the form of multi-cellular spheroids. The cells can be derived from patient tumors (primary cells), from patient-derived xenografts, or from genetically- or chemically induced animal tumors. This method of culturing spheroids composed of cells derived from cancer tissues can be applied to various types of cancer, including urothelial cancer. The method is based on the principle of retaining cell-cell contact throughout cancer cell preparation and culturing. The first step is a partial digestion of the tumor specimen into small fragments; these fragments spontaneously form spheroidal shapes within several hours. The spheroid is referred to as a cancer tissue-originated spheroid (CTOS). The advantage of the CTOS method is that it allows one to prepare pure cancer cells at high yield. CTOSs can be stably cultured in serum-free conditions. The CTOS method can be applied to drug sensitivity assays, drug screening, and analyses of intracellular signaling. Moreover, the CTOS method provides a platform for studying the nature of cancer cell clusters.
This is a preview of subscription content, log in via an institution to check access.
References
Sharma SV, Haber DA, Settleman J (2010) Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents. Nat Rev Cancer 10(4):241–253
Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S et al (2012) The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483(7391):603–607
Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT et al (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339(6119):580–584
Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA et al (2014) Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158(5):1110–1122
Yoshida T, Okuyama H, Nakayama M, Endo H, Tomita Y, Nonomura N et al (2015) Dynamic change in p63 protein expression during implantation of urothelial cancer clusters. Neoplasia 17(7):574–585
Bedard PL, Hansen AR, Ratain MJ, Siu LL (2013) Tumour heterogeneity in the clinic. Nature 501(7467):355–364
Cancer Genome Atlas Research N, Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA et al (2013) The cancer genome atlas pan-cancer analysis project. Nat Genet 45(10):1113–1120
Mitra A, Mishra L, Li S (2013) Technologies for deriving primary tumor cells for use in personalized cancer therapy. Trends Biotechnol 31(6):347–354
Kondo J, Endo H, Okuyama H, Ishikawa O, Iishi H, Tsujii M et al (2011) Retaining cell-cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer. Proc Natl Acad Sci U S A 108(15):6235–6240
Takeda T, Okuyama H, Nishizawa Y, Tomita S, Inoue M (2012) Hypoxia inducible factor-1alpha is necessary for invasive phenotype in Vegf-deleted islet cell tumors. Sci Rep 2:494
Okuyama H, Yoshida T, Endo H, Nakayama M, Nonomura N, Nishimura K et al (2013) Involvement of heregulin/HER3 in the primary culture of human urothelial cancer. J Urol 190(1):302–310
Yoshida T, Okuyama H, Nakayama M, Endo H, Nonomura N, Nishimura K et al (2015) High-dose chemotherapeutics of intravesical chemotherapy rapidly induce mitochondrial dysfunction in bladder cancer-derived spheroids. Cancer Sci 106(1):69–77
Kiyohara Y, Yoshino K, Kubota S, Okuyama H, Endo H, Ueda Y et al (2016) Drug screening and grouping by sensitivity with a panel of primary cultured cancer spheroids derived from endometrial cancer. Cancer Sci 107(4):452–460
Endo H, Okami J, Okuyama H, Kumagai T, Uchida J, Kondo J et al (2013) Spheroid culture of primary lung cancer cells with neuregulin 1/HER3 pathway activation. J Thorac Oncol 8(2):131–139
Nakajima A, Endo H, Okuyama H, Kiyohara Y, Kimura T, Kamiura S et al (2015) Radiation sensitivity assay with a panel of patient-derived spheroids of small cell carcinoma of the cervix. Int J Cancer 136(12):2949–2960
Knowles MA, Hurst CD (2015) Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer 15(1):25–41
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Yoshida, T., Okuyama, H., Endo, H., Inoue, M. (2018). Spheroid Cultures of Primary Urothelial Cancer Cells: Cancer Tissue-Originated Spheroid (CTOS) Method. In: Schulz, W., Hoffmann, M., Niegisch, G. (eds) Urothelial Carcinoma. Methods in Molecular Biology, vol 1655. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7234-0_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7234-0_12
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7233-3
Online ISBN: 978-1-4939-7234-0
eBook Packages: Springer Protocols